Glenmark Pharma US subsidiary agrees to $15.28 million settlement with Humana in generic drug antitrust case
· livemint.com
Glenmark Pharma’s US subsidiary has agreed to pay $15.28 million to settle antitrust litigation with Humana over allegations involving generic drug pricing and market allocation.
Glenmark Pharmaceuticals Ltd’s US subsidiary has agreed to pay $15.28 million to settle antitrust litigation with Humana Inc. involving allegations of price-f...